ProMED

What ProMED does

ProMED (Program for Monitoring Emerging Diseases) is a 24/7 global infectious disease outbreak surveillance service operated as a program of the International Society for Infectious Diseases (ISID), a Boston-based nonprofit professional organization. Founded in 1994 and maintaining a 31-year historical archive, ProMED curates and publishes outbreak intelligence across human, animal, and plant health using a One Health approach, staffed by ISID personnel plus a network of approximately 30 subject matter experts based in 24 countries who verify 5–20 critical health events daily and operate regional editions in multiple languages including English, Spanish, Russian, Portuguese, and Arabic.

The platform's core technology is human expert moderation supplemented by an AI Summary NLP layer that generates text digests of curated reports. Distribution is direct via a four-tier subscription model: a free Freemium tier with limited articles and truncated AI summaries, a Standard tier at $10/month (or $100/year), a Pro tier at $1,000/year for OECD small businesses, and a custom-priced Commercial/Government/Academic Research tier that includes bulk API access, webhooks, and multi-user organization accounts. Enterprise pricing is handled through a dedicated inquiry form, and the platform also solicits donations through Donorbox to sustain operations amid cited public health funding instability.

ProMED serves a globally distributed customer base spanning WHO, the US CDC, government health officials, physicians, veterinarians, academic researchers, journalists, AI-based disease surveillance platforms, and commercial organizations. Its go-to-market combines community-led acquisition (reputation, ISID ecosystem, global health conferences including ISID/ESCMID Global and ISID Congress) with sales-led enterprise motions for institutional and government contracts, and ecosystem partnerships with platforms such as Samdesk, GIDEON, EpiCore, and Transmissible that embed ProMED data into downstream operational and clinical workflows.

Name

ProMED

Legal name

International Society for Infectious Diseases

Website

https://promedmail.org

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

ProMED, a program of the International Society for Infectious Diseases, operates a 24/7 human-curated global infectious disease outbreak surveillance platform spanning human, animal, and plant health, serving WHO, CDC, governments, researchers, clinicians, and commercial users via tiered subscriptions, API access, and donations.

Ownership category

akta.pro rank

Product category

Disease Surveillance and Outbreak Intelligence

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Computer Systems Design and Related Services (5415), Administration of Public Health Programs (923120)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Disease & Condition Surveillance Programs (HLAJANAB)

akta.pro secondary industries

Outbreak Investigation & Incident Management (EOC/ICS) (HLAJABAE), Population Health Surveillance & Epidemiologic Analytics (HLAJAJAB), Public Health & Immunization Data Exchange (ELR, case reporting, registry reporting) (HLACABAL), Disease Surveillance, Epidemiology & Outbreak Response (BPAIAJAA)

Keywords

• Infectious disease surveillance
• Disease outbreak reporting
• Global health monitoring
• Epidemic intelligence platform
• Public health alerts

Headquarters

HQ city

Brookline

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Subscription Revenue: ProMED generates revenue through tiered subscription plans: Freemium (free), Standard ($10/month or $100/year), Pro ($1,000/year), and Custom pricing for Commercial/Government/Academic institutions. The platform relies on donations from worldwide users to continue providing real-time disease outbreak information amid public health funding instability.
2. Donations: ProMED accepts donations from worldwide users to maintain its global outbreak reporting services. The platform has called for support amid ongoing public health funding instability.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

ProMED (Program for Monitoring Emerging Diseases) operates a 24/7 global disease surveillance platform providing real-time, expert-curated outbreak reports across human, animal, and plant health. The platform is staffed by 30+ subject matter experts in 24 countries who verify and analyze 5-20 critical health events daily, supported by AI-generated summaries and a 31-year historical archive. It is offered via tiered subscriptions (Freemium, Standard, Pro, Commercial/Government/Academic Research) with API and webhook access for enterprise users, and serves WHO, CDC, universities, governments, physicians, veterinarians, and journalists worldwide.

Product overview

ProMED (Program for Monitoring Emerging Diseases) is a unified disease surveillance platform operated by the International Society for Infectious Diseases (ISID), launched in 1994. The core product is the ProMED Disease Surveillance Platform providing 24/7 global outbreak reporting across human, animal, and plant health using a One Health approach. The platform is supplemented by ProMED's Weekly Pulse for weekly summaries. ProMED offers a tiered subscription model: Freemium (free, limited), Standard ($10/mo), Pro ($1,000/yr), and Commercial/Government/Academic Research (custom pricing with API/webhook access). AI Summary functionality generates text summaries of reports across all paid tiers. The platform maintains a 31-year historical archive and is staffed by 30 subject matter experts across 24 countries.

Differentiator

Problem solved

Functional benefit

Products and services

• ProMED Disease Surveillance Platform The flagship 24/7 global infectious disease outbreak reporting platform covering human, animal, and plant health using a One Health approach. Provides expert-curated outbreak reports verified by 30+ subject matter experts in 24 countries, supported by a 31-year historical archive, customizable search, AI-generated summaries, and tiered subscription access. Used by the WHO, US CDC, universities, governments, physicians, veterinarians, and journalists worldwide.
• ProMED's Weekly Pulse A weekly snapshot of global health events from the past seven days, providing curated summaries of recent disease outbreak activity. Delivered via the ProMED website to complement the real-time core reporting stream.
• ProMED Commercial / Government / Academic Research Subscription

Quantifiable outcome

• First to report numerous major disease outbreaks including SARS, Chikungunya, early Ebola spread, Zika, MERS, and COVID-19
• +2 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• SamdeskcoreGTM or Marketing PartnerSamdesk is a Preferred Partner of ProMED, integrating real-time ProMED outbreak alerts into their operational intelligence platform. Samdesk processes text and sensory data to support safer, more efficient organizations and societies, providing real-time alerts to operational disruptions. This partnership extends ProMED's reach into corporate and government operational security markets.
• GIDEON (GIDEON Informatics)minorOthersGIDEON is listed as a user partner on ProMED's Preferred Partners page. GIDEON provides global infectious disease database tools used by healthcare professionals worldwide.
• EpiCoreminorOthersEpiCore is listed as a user partner on ProMED's Preferred Partners page. EpiCore is a global network of health professionals sharing surveillance information.
• Transmissible (TGH)minorOthersTransmissible (TGH) is listed as a user partner on ProMED's Preferred Partners page.
• International Society for Infectious Diseases (ISID)coreStrategic or Co-development PartnerProMED is a program of the International Society for Infectious Diseases (ISID). ISID provides institutional support, staffing, and organizational infrastructure. The society operates from 867 Boylston Street, Boston, MA 02116, USA. ISID also hosts major conferences including ISID/ESCMID Global and ISID Congress where ProMED maintains a presence.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Flu Near You / Outbreaks Near You (Boston Children's Hospital): Outbreaks Near You aggregates crowdsourced and traditional surveillance signals for public-facing outbreak tracking. It is a narrower, public-facing adjacent surveillance platform rather than a full ProMED competitor.
• EpiCore: EpiCore is a verified network of human health professionals that crowdsources and validates surveillance signals using a similar expert-moderation approach to ProMED. It is a Preferred Partner of ProMED but represents an adjacent, narrower community-led threat.
• AstraZeneca Foundation Disease Surveillance / Ending Pandemics: Ending Pandemics (formerly InSTEDD iLab) supports volunteer-based disease surveillance networks (e.g., in Thailand and Sri Lanka) using community reporting infrastructure analogous to ProMED's expert network. Operates in a smaller scope but uses a comparable human-network approach.

Direct peers

• HealthMap: HealthMap (Boston Children's Hospital / Harvard Medical School) is one of the most well-known real-time infectious disease surveillance aggregators. Like ProMED, it ingests global signals and surfaces outbreak alerts to public health users, making it a closely comparable direct peer in disease intelligence.
• BlueDot: BlueDot is a Toronto-based AI-driven global infectious disease intelligence platform that monitors, contextualizes, and forecasts outbreaks for government and enterprise clients. It is the canonical 'AI-native' counterpart to ProMED's expert-curated model.
• GIDEON Informatics: GIDEON is a long-standing infectious disease reference and surveillance database used by clinicians and public health professionals. It is already listed as a ProMED user partner, shares the same target buyer base (physicians, epidemiologists), and competes for paid subscriptions in the same intelligence category.
• Metabiota: Metabiota built an epidemic risk platform using global infectious disease surveillance data for insurers, governments, and humanitarian organizations. It competes for the same institutional outbreak-intelligence budgets that ProMED targets with its Commercial tier.

Broad incumbents

• CIDRAP (Center for Infectious Disease Research and Policy): CIDRAP at the University of Minnesota publishes curated, expert-vetted outbreak and policy news to a global health audience. It serves overlapping public-health and research subscribers and is a broad incumbent rather than a direct subscription competitor.

Others

• World Health Organization DON (Disease Outbreak News): WHO's Disease Outbreak News is the official agency output that ProMED often pre-empts. They are both authoritative outbreak-information sources, but WHO is a public-sector publisher while ProMED is a curated subscription/feed product.
• HealthLine / Outbreak News Today: Outbreak News Today publishes continuously curated global outbreak summaries for journalists and health-conscious readers. It overlaps significantly with ProMED's media/journalist segment but redistributes rather than originates primary reporting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/promed_mail
• Facebookfacebook.com/promedmail
• LinkedInlinkedin.com/company/promed-mail

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ProMED